Edition:
United Kingdom

Bruker Corp (BRKR.OQ)

BRKR.OQ on NASDAQ Stock Exchange Global Select Market

35.20USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$35.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
160,260
52-wk High
$36.51
52-wk Low
$21.83

Chart for

About

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies... (more)

Overall

Beta: 1.04
Market Cap(Mil.): $4,815.49
Shares Outstanding(Mil.): 158.35
Dividend: 0.04
Yield (%): 0.53

Financials

  Industry Sector
P/E (TTM): -- 149.38 16.58
EPS (TTM): -- -- --
ROI: -- 9.44 10.60
ROE: -- 14.87 14.19

BRIEF-Bruker reports third quarter 2017 financial results

* Q3 revenue $435.6 million versus I/B/E/S view $414.6 million

02 Nov 2017

BRIEF-Bruker acquires Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper platform

* Bruker announces acquisition of Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper® microbial identification platform

26 Sep 2017

BRIEF-Bruker acquires XGLab with X-ray detection technologies, XRF instruments

* Bruker acquires company XGLab with unique X-ray detection technologies and XRF instruments for art & conservation markets

07 Aug 2017

BRIEF-Bruker Q2 non-gaap earnings per share $0.23

* Q2 revenue $414.9 million versus I/B/E/S view $385.5 million

03 Aug 2017

BRIEF-Bruker announces US FDA clearance of expanded 3rd claim for Maldi Biotyper

* Bruker announces US FDA clearance of expanded 3rd claim for Maldi Biotyper Source text for Eikon: Further company coverage:

31 Jul 2017

Competitors

Earnings vs. Estimates